Amplifon SpA
OTC:AMFPF
Relative Value
The Relative Value of one AMFPF stock under the Base Case scenario is 50.46 USD. Compared to the current market price of 29.87 USD, Amplifon SpA is Undervalued by 41%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
AMFPF Competitors Multiples
Amplifon SpA Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
IT |
Amplifon SpA
OTC:AMFPF
|
7.1B USD | 3.2 | 45.9 | 14.8 | 29.2 | ||
US |
Mckesson Corp
NYSE:MCK
|
69.3B USD | 0.2 | 23.1 | 16.1 | 18.7 | ||
US |
Cencora Inc
NYSE:COR
|
44.7B USD | 0.2 | 24.1 | 16.7 | 16.7 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24.1B USD | 0.1 | 37.8 | 8.4 | 11.3 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
US |
Henry Schein Inc
NASDAQ:HSIC
|
8.8B USD | 0.7 | 21.1 | 11.2 | 15 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.6B CNY | 1.4 | 21.3 | 15.5 | 15.5 | ||
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
61.2B HKD | 0.1 | 6.4 | 1.5 | 1.8 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51B CNY | 0.2 | 13.5 | 8 | 8 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |